Providing for a prescription drug access program; requiring prescription manufacturers or labelers selling prescription drugs through the medical assistance (MA) program or other publicly supported pharmaceutical assistance program to enter into agreements with the commissioner of administration for rebate payments to the state, requiring and providing for the commissioner to negotiate the rebate amount; requiring participating retail pharmacies covered by a rebate agreement to discount the retail price of drugs sold to eligible individuals, requiring the commissioner to establish discounted prices for drugs covered by the agreements and to promote the use of efficacious and reduced cost drugs, requiring pharmacies to offer initial and secondary discounted prices by certain dates; requiring the board of pharmacy to adopt rules requiring disclosure by participating pharmacies to eligible individuals the amount of savings resulting from the prescription drug access program; prohibiting the commissioner from imposing transaction charges on participating pharmacies submitting claims or receiving payments under the program and specifying certain duties of the commissioner relating to reimbursement to pharmacies for discounted prices and certain authorized professional fees and the collection of utilization data, providing for the confidentiality of certain information; requiring and providing for commissioner release of the names of manufacturers and labelers participating and not participating in rebate agreements to health care providers and the public on a regular basis; requiring the commissioner of human services to impose prior authorization requirements in the medical assistance program for the dispensing of prescription drugs provided by manufacturers and labelers without rebate agreements; requiring and providing for the resolution of discrepancies in rebate amounts; establishing the prescription drug fund and appropriating money in the fund to the commissioner of administration for program administration purposes; requiring the commissioner to annually report the enrollment and financial status of the program to the legislature; requiring the commissioner to establish procedures for determining eligibility and issuing enrollment cards to eligible individuals and to promote awareness and authorizing the commissioner to contract for administration of the program; requiring the commissioner in cooperation with the commissioner of human services to administer the program and other medical and pharmaceutical assistance programs in an advantageous coordinated manner; authorizing commissioner implementation rules and federal waivers (mk)